uniQure N.V.

QURE

...

QURE: uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Show QURE Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of QURE by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by QURE's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on QURE's company Twitter account

WallStreetBets

Number of mentions of QURE in WallStreetBets Daily Discussion

QURE News

Recent insights relating to QURE

CNBC Recommendations

Recent picks made for QURE stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in QURE

Corporate Flights

Flights by private jets registered to QURE